However, in August 2019, Organovo was forced to explore "strategic alternatives" when it discovered that its approach to fabricating liver tissue required significant redevelopment, and the company has since made efforts to preserve cash, but its website has remained devoid of any updates on the progress of its technologies for the last two years.